Mesenchymal stem cell exosome-derived miR-223 alleviates acute graft-versus-host disease via reducing the migration of donor T cells

BACKGROUND: Mesenchymal stem cells (MSCs) have been utilized in treating acute graft-versus-host disease (aGvHD) as they show strong immunosuppressive capacity through the release of various mediators, including immunosuppressive molecules, growth factors, chemokines, and exosomes. MicroRNAs (miRNAs...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Weijiang, Zhou, Na, Liu, Yuanlin, Zhang, Wei, Li, Xue, Wang, Yang, Zheng, Rongxiu, Zhang, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913292/
https://www.ncbi.nlm.nih.gov/pubmed/33637123
http://dx.doi.org/10.1186/s13287-021-02159-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913292/
https://www.ncbi.nlm.nih.gov/pubmed/33637123
http://dx.doi.org/10.1186/s13287-021-02159-2

Ejemplares similares